Children's Hospital Association submitted comments on the cell and gene therapy request for information (RFI) from Sen. Bill Cassidy (R-La.), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee. Our response highlights the need to ensure children’s equitable access to these therapies and a strong national framework for payment and oversight.
CHA Response to Cell and Gene Therapy RFI
Cell and gene therapies have the potential to address unmet pediatric medical needs, reduce the need for costly chronic care, and help address health disparities.
Related Content
Pharmacy Technicians Capture 98% of Medication Histories
Specially trained technicians catch errors before they reach patients and remove the burden from nurses.
Sep. 10, 2026
This Children’s Hospital Reduced Asthma ED Visits by 70%
A comprehensive asthma program resulted in fewer hospitalizations and emergency visits and earned a rare Joint Commission certification.
Sep. 10, 2026
How CHA Mitigated a Cancer Drug Shortage’s Impact
The recent shortage highlighted pediatrics’ vital need for ifosfamide.
Sep. 01, 2026
